Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 13Withdrawn 3Terminated 3Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Prostatic Neoplasms 51Lung Neoplasms 40Carcinoma, Non-Small-Cell Lung 28Neoplasm Metastasis 25Brain Neoplasms 23Pancreatic Neoplasms 22Lymphoma, Large B-Cell, Diffuse 22Glioma 20Breast Neoplasms 20Squamous Cell Carcinoma of Head and Neck 17Glioblastoma 17Multiple Myeloma 16Colorectal Neoplasms 14Carcinoma, Renal Cell 13Urinary Bladder Neoplasms 12Mouth Neoplasms 11Lymphoma, Mantle-Cell 11Triple Negative Breast Neoplasms 10Oropharyngeal Neoplasms 10Melanoma 10Leukemia, Lymphocytic, Chronic, B-Cell 10Carcinoma 10Ovarian Neoplasms 9Laryngeal Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Nasopharyngeal Carcinoma 8Lymphoma, Follicular 8Leukemia, Myeloid, Acute 8Lymphoma, B-Cell 7Hypopharyngeal Neoplasms 7

Interventions

pembrolizumab 3Temozolomide 3Specimen Handling 3Radiotherapy 2peposertib 1liposomal doxorubicin 1gosha-jinki-gan 1efineptakin alfa 1cabozantinib 1balstilimab 1atezolizumab 1abexinostat 1Surgical Procedures, Operative 1Radiation 1ONC206 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Gliosarcoma × Magnetic Resonance Spectroscopy × Clear all
NCT07301268 2026-04-08

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Mayo Clinic

Phase 2 Recruiting
36 enrolled
CNSSarcoma

Astrocytoma, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡